Dettol maker says sales looking strong but warns of inflation

Reckitt said the cost of production is rising and that Lysol disinfectant sales have taken a hit.

Simon Neville
Friday 29 April 2022 02:50 EDT
Dettol maker says sales are at the top end of expectations but costs are rise. (Matt Alexander / PA)
Dettol maker says sales are at the top end of expectations but costs are rise. (Matt Alexander / PA) (PA Archive)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Durex and Air Wick maker Reckitt said it expects sales to be at the top end of market expectations but warned that the cost of production continues to soar.

The company revealed sales fell 2.3% in the first three months of the year to £3.4 billion, but on a like-for-like basis, stripping out selling off some of its brands, sales were up 5.6%.

Its hygiene division suffered the most during the period, dropping 9% like-for-like due to heavy falls in sales of its Lysol disinfectant products when compared to strong sales during the height of the pandemic a year earlier.

Excluding Lysol sales, growth in the hygiene division, which includes brands like Finish, Air Wick, Harpic and Vanish, sales were up 3.9%.

Reckitt’s health division, including Lemsip, Strepsils and its Durex condom range, rose 20.6% on a like-for-like basis.

Dettol is “in line with expectations” and on track for low single digit growth during the year, although the company did not say whether it had suffered a fall in sales during the first three months of the year.

The company’s nutrition division saw like-for-like growth of 20.4% with strong sales in the US.

Reckitt chief executive Laxman Narasimhan said it had been a strong start to the year despite a challenging operating environment.

He added: “As we look to the balance of the year, the operating environment remains highly unpredictable.

“We are well placed to address these market dynamics through the strength of our brands, our favourable product mix, our productivity programme and the responsible pricing initiatives already undertaken, with scope to take further actions.”

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in